Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease (COPD)

26. Juni 2014 aktualisiert von: Boehringer Ingelheim

Drug Use Results Survey of Tiotropium Bromide

To collect post-marketing safety and effectiveness information on the use of Tiotropium Inhalation Capsules (18 μg) in patients with chronic obstructive pulmonary disease in daily clinical settings

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

3588

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

  • Japan
      • Abashiri, Japan
        • Boehringer Ingelheim Investigational Site
      • Aizubangemachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Aizumisatomachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Aizuwakamatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Akashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Akita, Japan
        • Boehringer Ingelheim Investigational Site
      • Ako, Japan
        • Boehringer Ingelheim Investigational Site
      • Amagasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Amakusa, Japan
        • Boehringer Ingelheim Investigational Site
      • Amimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Anan, Japan
        • Boehringer Ingelheim Investigational Site
      • Anjo, Japan
        • Boehringer Ingelheim Investigational Site
      • Arakawamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Arao, Japan
        • Boehringer Ingelheim Investigational Site
      • Aritacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Asahikawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Ashikaga, Japan
        • Boehringer Ingelheim Investigational Site
      • Atami, Japan
        • Boehringer Ingelheim Investigational Site
      • Atsugi, Japan
        • Boehringer Ingelheim Investigational Site
      • Awa, Japan
        • Boehringer Ingelheim Investigational Site
      • Ayabe, Japan
        • Boehringer Ingelheim Investigational Site
      • Ayagawacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Ayase, Japan
        • Boehringer Ingelheim Investigational Site
      • Beppu, Japan
        • Boehringer Ingelheim Investigational Site
      • Bibai, Japan
        • Boehringer Ingelheim Investigational Site
      • Bungoohno, Japan
        • Boehringer Ingelheim Investigational Site
      • Chiba, Japan
        • Boehringer Ingelheim Investigational Site
      • Chigasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Chikusei, Japan
        • Boehringer Ingelheim Investigational Site
      • Chikushino, Japan
        • Boehringer Ingelheim Investigational Site
      • Chitose, Japan
        • Boehringer Ingelheim Investigational Site
      • Date, Japan
        • Boehringer Ingelheim Investigational Site
      • Ebetsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Echizen, Japan
        • Boehringer Ingelheim Investigational Site
      • Emukaecho, Japan
        • Boehringer Ingelheim Investigational Site
      • Engarucho, Japan
        • Boehringer Ingelheim Investigational Site
      • Fuchuu, Japan
        • Boehringer Ingelheim Investigational Site
      • Fuji, Japan
        • Boehringer Ingelheim Investigational Site
      • Fujiidera, Japan
        • Boehringer Ingelheim Investigational Site
      • Fujikawaguchiko, Japan
        • Boehringer Ingelheim Investigational Site
      • Fujinomiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukaya, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukuchiyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukui, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukuoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukuroi, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukushima, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukutsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Funabashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Futabamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Geiseimura, Japan
        • Boehringer Ingelheim Investigational Site
      • Gifu, Japan
        • Boehringer Ingelheim Investigational Site
      • Ginowan, Japan
        • Boehringer Ingelheim Investigational Site
      • Gobo, Japan
        • Boehringer Ingelheim Investigational Site
      • Gosen, Japan
        • Boehringer Ingelheim Investigational Site
      • Gotenba, Japan
        • Boehringer Ingelheim Investigational Site
      • Gyouda, Japan
        • Boehringer Ingelheim Investigational Site
      • Habikino, Japan
        • Boehringer Ingelheim Investigational Site
      • Hachinohe, Japan
        • Boehringer Ingelheim Investigational Site
      • Hachirogatamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hagi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hakodate, Japan
        • Boehringer Ingelheim Investigational Site
      • Hakusan, Japan
        • Boehringer Ingelheim Investigational Site
      • Hamada, Japan
        • Boehringer Ingelheim Investigational Site
      • Hamamatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Handa, Japan
        • Boehringer Ingelheim Investigational Site
      • Hanyuu, Japan
        • Boehringer Ingelheim Investigational Site
      • Hatsukaichi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hayashimacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Higashihiroshima, Japan
        • Boehringer Ingelheim Investigational Site
      • Higashimatsushima, Japan
        • Boehringer Ingelheim Investigational Site
      • Higashiomi, Japan
        • Boehringer Ingelheim Investigational Site
      • Higashiosaka, Japan
        • Boehringer Ingelheim Investigational Site
      • Hikari, Japan
        • Boehringer Ingelheim Investigational Site
      • Himeji, Japan
        • Boehringer Ingelheim Investigational Site
      • Hirakata, Japan
        • Boehringer Ingelheim Investigational Site
      • Hiratsuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Hirosaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Hiroshima, Japan
        • Boehringer Ingelheim Investigational Site
      • Hita, Japan
        • Boehringer Ingelheim Investigational Site
      • Hitachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hitoyoshi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hofu, Japan
        • Boehringer Ingelheim Investigational Site
      • Iamabari, Japan
        • Boehringer Ingelheim Investigational Site
      • Ibaraki, Japan
        • Boehringer Ingelheim Investigational Site
      • Ibarakimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Ibigawacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Ibusuki, Japan
        • Boehringer Ingelheim Investigational Site
      • Ichihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Ichinomiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Ichinoseki, Japan
        • Boehringer Ingelheim Investigational Site
      • Iga, Japan
        • Boehringer Ingelheim Investigational Site
      • Iida, Japan
        • Boehringer Ingelheim Investigational Site
      • Iizuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Ikoma, Japan
        • Boehringer Ingelheim Investigational Site
      • Imari, Japan
        • Boehringer Ingelheim Investigational Site
      • Imizu, Japan
        • Boehringer Ingelheim Investigational Site
      • Ina, Japan
        • Boehringer Ingelheim Investigational Site
      • Inazawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Inuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Isahaya, Japan
        • Boehringer Ingelheim Investigational Site
      • Ise, Japan
        • Boehringer Ingelheim Investigational Site
      • Isehara, Japan
        • Boehringer Ingelheim Investigational Site
      • Ishikari, Japan
        • Boehringer Ingelheim Investigational Site
      • Ishinomaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Itami, Japan
        • Boehringer Ingelheim Investigational Site
      • Itanocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Ito, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwakuni, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwamizawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwanaicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwata, Japan
        • Boehringer Ingelheim Investigational Site
      • Iyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Izu, Japan
        • Boehringer Ingelheim Investigational Site
      • Izumisano, Japan
        • Boehringer Ingelheim Investigational Site
      • Izumo, Japan
        • Boehringer Ingelheim Investigational Site
      • Izunokuni, Japan
        • Boehringer Ingelheim Investigational Site
      • Jimokujicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Joso, Japan
        • Boehringer Ingelheim Investigational Site
      • Jouetsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Joyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Kaga, Japan
        • Boehringer Ingelheim Investigational Site
      • Kagoshima, Japan
        • Boehringer Ingelheim Investigational Site
      • Kaizuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Kajikicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Kakegawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Kami, Japan
        • Boehringer Ingelheim Investigational Site
      • Kamiamakusa, Japan
        • Boehringer Ingelheim Investigational Site
      • Kamisu, Japan
        • Boehringer Ingelheim Investigational Site
      • Kanazawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Kandamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kanonji, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasai, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasama, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasaoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Kashihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Kashima, Japan
        • Boehringer Ingelheim Investigational Site
      • Kashiwazaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasuga, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasuigai, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasukabe, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasuyamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kato, Japan
        • Boehringer Ingelheim Investigational Site
      • Katsuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawachinagano, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawagoe, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawaguchi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawanishimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Kayano, Japan
        • Boehringer Ingelheim Investigational Site
      • Kazuno, Japan
        • Boehringer Ingelheim Investigational Site
      • Kinkocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Kitakami, Japan
        • Boehringer Ingelheim Investigational Site
      • Kitakyushu, Japan
        • Boehringer Ingelheim Investigational Site
      • Kitami, Japan
        • Boehringer Ingelheim Investigational Site
      • Kobe, Japan
        • Boehringer Ingelheim Investigational Site
      • Kochi, Japan
        • Boehringer Ingelheim Investigational Site
      • Koga, Japan
        • Boehringer Ingelheim Investigational Site
      • Komonocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Konan, Japan
        • Boehringer Ingelheim Investigational Site
      • Koriyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Kouriyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Koushi, Japan
        • Boehringer Ingelheim Investigational Site
      • Koushu, Japan
        • Boehringer Ingelheim Investigational Site
      • Kozakaicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Kudamatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Kumamoto, Japan
        • Boehringer Ingelheim Investigational Site
      • Kunimimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kunisaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Kurashiki, Japan
        • Boehringer Ingelheim Investigational Site
      • Kurayoshi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kure, Japan
        • Boehringer Ingelheim Investigational Site
      • Kurihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Kurume, Japan
        • Boehringer Ingelheim Investigational Site
      • Kushiro, Japan
        • Boehringer Ingelheim Investigational Site
      • Kuwana, Japan
        • Boehringer Ingelheim Investigational Site
      • Kyotango, Japan
        • Boehringer Ingelheim Investigational Site
      • Kyoto, Japan
        • Boehringer Ingelheim Investigational Site
      • Maebashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Marugame, Japan
        • Boehringer Ingelheim Investigational Site
      • Masuda, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsudo, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsue, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsumoto, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsusaka, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Mibumachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Mihamacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Mihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Minamisatsuma, Japan
        • Boehringer Ingelheim Investigational Site
      • Minamisouma, Japan
        • Boehringer Ingelheim Investigational Site
      • Minamiuonuma, Japan
        • Boehringer Ingelheim Investigational Site
      • Mino, Japan
        • Boehringer Ingelheim Investigational Site
      • Minoh, Japan
        • Boehringer Ingelheim Investigational Site
      • Misasacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Misato, Japan
        • Boehringer Ingelheim Investigational Site
      • Mishima, Japan
        • Boehringer Ingelheim Investigational Site
      • Mito, Japan
        • Boehringer Ingelheim Investigational Site
      • Miyakicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Miyakonojo, Japan
        • Boehringer Ingelheim Investigational Site
      • Miyazaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Miyoshi, Japan
        • Boehringer Ingelheim Investigational Site
      • Mizunami, Japan
        • Boehringer Ingelheim Investigational Site
      • Mobara, Japan
        • Boehringer Ingelheim Investigational Site
      • Moriguchi, Japan
        • Boehringer Ingelheim Investigational Site
      • Morioka, Japan
        • Boehringer Ingelheim Investigational Site
      • Muroran, Japan
        • Boehringer Ingelheim Investigational Site
      • Nabari, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagahama, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagano, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagaoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagato, Japan
        • Boehringer Ingelheim Investigational Site
      • Nago, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagoya, Japan
        • Boehringer Ingelheim Investigational Site
      • Naha, Japan
        • Boehringer Ingelheim Investigational Site
      • Nakama, Japan
        • Boehringer Ingelheim Investigational Site
      • Nakashibetsucho, Japan
        • Boehringer Ingelheim Investigational Site
      • Nanao, Japan
        • Boehringer Ingelheim Investigational Site
      • Nankoku, Japan
        • Boehringer Ingelheim Investigational Site
      • Nantan, Japan
        • Boehringer Ingelheim Investigational Site
      • Nara, Japan
        • Boehringer Ingelheim Investigational Site
      • Naruto, Japan
        • Boehringer Ingelheim Investigational Site
      • Nasukarasuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Neyagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Nihonmatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Niigata, Japan
        • Boehringer Ingelheim Investigational Site
      • Niihamashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Nikko, Japan
        • Boehringer Ingelheim Investigational Site
      • Nishiiyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Nishinomiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Nishio, Japan
        • Boehringer Ingelheim Investigational Site
      • Nobeoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Noboribetsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Noda, Japan
        • Boehringer Ingelheim Investigational Site
      • Nomi, Japan
        • Boehringer Ingelheim Investigational Site
      • Noshiro, Japan
        • Boehringer Ingelheim Investigational Site
      • Notocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Numata, Japan
        • Boehringer Ingelheim Investigational Site
      • Numazu, Japan
        • Boehringer Ingelheim Investigational Site
      • Oaraimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Obama, Japan
        • Boehringer Ingelheim Investigational Site
      • Obihiro, Japan
        • Boehringer Ingelheim Investigational Site
      • Odate, Japan
        • Boehringer Ingelheim Investigational Site
      • Odawara, Japan
        • Boehringer Ingelheim Investigational Site
      • Ogawaramachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Ogi, Japan
        • Boehringer Ingelheim Investigational Site
      • Oita, Japan
        • Boehringer Ingelheim Investigational Site
      • Ojiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Okayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Okinawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Omihachiman, Japan
        • Boehringer Ingelheim Investigational Site
      • Omuta, Japan
        • Boehringer Ingelheim Investigational Site
      • Onomachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Osaka, Japan
        • Boehringer Ingelheim Investigational Site
      • Osakasayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Ota, Japan
        • Boehringer Ingelheim Investigational Site
      • Otake, Japan
        • Boehringer Ingelheim Investigational Site
      • Otaru, Japan
        • Boehringer Ingelheim Investigational Site
      • Otsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Otsumachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Owariasahi, Japan
        • Boehringer Ingelheim Investigational Site
      • Ritto, Japan
        • Boehringer Ingelheim Investigational Site
      • Ryugasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Sado, Japan
        • Boehringer Ingelheim Investigational Site
      • Saga, Japan
        • Boehringer Ingelheim Investigational Site
      • Sagamihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Saiki, Japan
        • Boehringer Ingelheim Investigational Site
      • Saitama, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakai, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakaimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakaiminato, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakata, Japan
        • Boehringer Ingelheim Investigational Site
      • Saku, Japan
        • Boehringer Ingelheim Investigational Site
      • Sanjyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Sanuki, Japan
        • Boehringer Ingelheim Investigational Site
      • Sanyoonoda, Japan
        • Boehringer Ingelheim Investigational Site
      • Sapporo, Japan
        • Boehringer Ingelheim Investigational Site
      • Sasayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Sasebo, Japan
        • Boehringer Ingelheim Investigational Site
      • Satsumasendai, Japan
        • Boehringer Ingelheim Investigational Site
      • Sayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Sendai, Japan
        • Boehringer Ingelheim Investigational Site
      • Sennan, Japan
        • Boehringer Ingelheim Investigational Site
      • Shibetsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Shibukawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Shimada, Japan
        • Boehringer Ingelheim Investigational Site
      • Shimonoseki, Japan
        • Boehringer Ingelheim Investigational Site
      • Shimotsuke, Japan
        • Boehringer Ingelheim Investigational Site
      • Shimotsuma, Japan
        • Boehringer Ingelheim Investigational Site
      • Shingu, Japan
        • Boehringer Ingelheim Investigational Site
      • Shiogama, Japan
        • Boehringer Ingelheim Investigational Site
      • Shirahamacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Shiroishi, Japan
        • Boehringer Ingelheim Investigational Site
      • Shiroishicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Shizuoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Shoocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Shunan, Japan
        • Boehringer Ingelheim Investigational Site
      • Soo, Japan
        • Boehringer Ingelheim Investigational Site
      • Souka, Japan
        • Boehringer Ingelheim Investigational Site
      • Suita, Japan
        • Boehringer Ingelheim Investigational Site
      • Sukagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Sukumo, Japan
        • Boehringer Ingelheim Investigational Site
      • Sunagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Susono, Japan
        • Boehringer Ingelheim Investigational Site
      • Suwa, Japan
        • Boehringer Ingelheim Investigational Site
      • Suzuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Tagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Tainai, Japan
        • Boehringer Ingelheim Investigational Site
      • Takahashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Takamatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Takaoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Takarazuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Takasago, Japan
        • Boehringer Ingelheim Investigational Site
      • Takashima, Japan
        • Boehringer Ingelheim Investigational Site
      • Takatsuki, Japan
        • Boehringer Ingelheim Investigational Site
      • Taku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tamana, Japan
        • Boehringer Ingelheim Investigational Site
      • Tamano, Japan
        • Boehringer Ingelheim Investigational Site
      • Tanabe, Japan
        • Boehringer Ingelheim Investigational Site
      • Taragimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Tenri, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokaimura, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokorozawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokunoshimacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokushima, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Adachi-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Akishima, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Bunkyo-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Chiyoda-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Edogawa-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Hachioji, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Higashimurayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Higashiyamato, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Hino, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Itabashi-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Katsushika-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Kiyose, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Komae, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Koto-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Meguro-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Minato-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Nakano-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Nerima-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Nishitokyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Ome, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Ota-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Setagaya-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Shibuya-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Shinagawa-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Shinjuku-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Suginami-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Sumida-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Taito-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Toshima-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tomakomai, Japan
        • Boehringer Ingelheim Investigational Site
      • Tomigusu, Japan
        • Boehringer Ingelheim Investigational Site
      • Tomioka, Japan
        • Boehringer Ingelheim Investigational Site
      • Tondabayashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Toride, Japan
        • Boehringer Ingelheim Investigational Site
      • Tottori, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyohashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyokawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyooka, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyosatocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyota, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsukuba, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsurugicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsuruoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsushima, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Ube, Japan
        • Boehringer Ingelheim Investigational Site
      • Uchikocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Uchinadamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Uekimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Uji, Japan
        • Boehringer Ingelheim Investigational Site
      • Uki, Japan
        • Boehringer Ingelheim Investigational Site
      • Unzen, Japan
        • Boehringer Ingelheim Investigational Site
      • Urakawacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Urasoe, Japan
        • Boehringer Ingelheim Investigational Site
      • Urayasu, Japan
        • Boehringer Ingelheim Investigational Site
      • Uruma, Japan
        • Boehringer Ingelheim Investigational Site
      • Usa, Japan
        • Boehringer Ingelheim Investigational Site
      • Usuki, Japan
        • Boehringer Ingelheim Investigational Site
      • Utsunomiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Wakayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Yabu, Japan
        • Boehringer Ingelheim Investigational Site
      • Yachimata, Japan
        • Boehringer Ingelheim Investigational Site
      • Yachiyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Yaizu, Japan
        • Boehringer Ingelheim Investigational Site
      • Yakumocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yakushimacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yamaga, Japan
        • Boehringer Ingelheim Investigational Site
      • Yamagata, Japan
        • Boehringer Ingelheim Investigational Site
      • Yamato, Japan
        • Boehringer Ingelheim Investigational Site
      • Yamatotakada, Japan
        • Boehringer Ingelheim Investigational Site
      • Yanai, Japan
        • Boehringer Ingelheim Investigational Site
      • Yao, Japan
        • Boehringer Ingelheim Investigational Site
      • Yatomi, Japan
        • Boehringer Ingelheim Investigational Site
      • Yatsushiro, Japan
        • Boehringer Ingelheim Investigational Site
      • Yawata, Japan
        • Boehringer Ingelheim Investigational Site
      • Yokkaichi, Japan
        • Boehringer Ingelheim Investigational Site
      • Yokohama, Japan
        • Boehringer Ingelheim Investigational Site
      • Yokosuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Yokote, Japan
        • Boehringer Ingelheim Investigational Site
      • Yonabarucho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yonezawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Yorocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yoshinocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yufu, Japan
        • Boehringer Ingelheim Investigational Site
      • Yurihonjou, Japan
        • Boehringer Ingelheim Investigational Site

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Kind
  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

COPD patients in daily clinical settings.

Beschreibung

Inclusion Criteria:

- Patients with COPD

Exclusion Criteria:

-There is no exclusion criterion, because this post marketing study (PMS) is observational survey under condition of normal clinical practice

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Patienten mit COPD
Arzneimittel: Spiriva (tiotropium bromide) inhalation capsules
Survey of patients with COPD using Spiriva (tiotropium bromide) inhalation capsules

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Number of patients with adverse events
Zeitfenster: Up to 4 weeks after start of treatment
Up to 4 weeks after start of treatment
Number of patients with adverse drug reactions
Zeitfenster: Up to 4 weeks after start of treatment
Up to 4 weeks after start of treatment
Number of patients with serious adverse events
Zeitfenster: Up to 4 weeks after start of treatment
Up to 4 weeks after start of treatment

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Physician's overall judgement by medical interview into four grades: 1. Improved 2. No Change 3. Aggravated 4.Unassessable
Zeitfenster: Up to 4 weeks after start of treatment
Up to 4 weeks after start of treatment

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Boehringer Ingelheim

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. April 2005

Primärer Abschluss (Tatsächlich)

1. September 2007

Studienanmeldedaten

Zuerst eingereicht

31. Januar 2008

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

26. Juni 2014

Zuerst gepostet (Schätzen)

27. Juni 2014

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Schätzen)

27. Juni 2014

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

26. Juni 2014

Zuletzt verifiziert

1. Juni 2014

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • 205.314

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Spiriva (tiotropium bromide) inhalation capsules

Suchen Sie nach ähnlichen Studien

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

CROs by country

CROs in Kyrgyzstan

Bedingungen

Seltene Krankheiten

Drogeninterventionen

Nahrungsergänzungsmittel

Sponsor / Mitarbeiter

Standorte

3
Abonnieren